课题基金 / 基金详情

New methods for carbon-11 radiotracer synthesis & application to NMDA PET imaging

New methods for carbon-11 radiotracer synthesis & application to NMDA PET imaging
碳11放射性示踪剂合成新方法
批准号:
7408205
负责人:
Jacob M. Hooker
金额:
$4.48万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-30 至 2010-09-29

项目摘要

项目成果

Jacob M. Hooker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Radiotracers have enabled investigations of molecular phenomena which are at the heart of understanding human disease and developing effective treatments. Yet, there exists a major deficiency in our ability to synthesize radiotracers. The focus of the research described herein is the development of new rapid chemical methods for the incorporation of readily available carbon-11 labeled precursors into common pharmacophore moieties for their use as radiotracers. The strategies are designed to target functional groups that are not adequately addressed by existing carbon-11 incorporation strategies. A particular focus is placed on radiolabeling compounds identified in the literature as candidates for the study and treatment of psychiatric and neurological disorders, with a special emphasis on addictive disorders. Specifically, the new chemical strategies we develop will be used to radiolabel a glutamate receptor antagonist. We will then evaluate the labeled compound as a radiotracer for positron emission tomography (PET).We will accomplish this in three specific aims. In Specific Aim 1, we will develop new rapid chemical reactions for the incorporation of carbon-11 into a) carbamate/carbonate functional groups and b) piperidine heterocycles. This will be accomplished by incorporating common [11C] labeling precursors, [11C]-carbon dioxide and [11C]-cyanide, using rapid organic synthesis. Carbonate and carbamate radiolabeling will be achieved by the direct chemical fixation of [11C]O2. Piperidine heterocycle labeling will be achieved through a novel reductive cyclization of 1,4-cyanoaldehydes prepared from [11C]N. In Specific Aim 2, we will evaluate these chemical strategies by radiolabeling a N-methyl-D-aspartate (NMDA) receptor antagonist. In Specific Aim 3, the radiolabeled antagonist will be evaluated as a radiotracer in vivo by PET. RELEVANCE: Advances in radiotracer chemistry and translational research directed to neurologicall targets involved in human brain dysfunction will accelerate the understanding of brain function and the development of effective treatments for brain disorders. The research proposed herein will advance radiotracer chemistry through the development of new methods for carbon-11 incorporation. These methods will be used for the synthesis of radiotracers to study brain dysfunction & neurological disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COX-2-Selective PET Imaging as an Onset Marker of Huntington's Disease
  • 批准号:
    10548808
  • 项目类别:
  • 资助金额:
    $62.04万
  • 财政年份:
    2019
  • 负责人:
    Jacob M. Hooker
  • 依托单位:
COX-2-selective PET imaging as an onset marker of Huntington's disease
  • 批准号:
    9883956
  • 项目类别:
  • 资助金额:
    $66.09万
  • 财政年份:
    2019
  • 负责人:
    Jacob M. Hooker
  • 依托单位:
COX-2-selective PET imaging as an onset marker of Huntington's disease
  • 批准号:
    10308680
  • 项目类别:
  • 资助金额:
    $64.78万
  • 财政年份:
    2019
  • 负责人:
    Jacob M. Hooker
  • 依托单位:
COX-2-selective PET imaging as an onset marker of Huntington's disease
  • 批准号:
    10061659
  • 项目类别:
  • 资助金额:
    $63.52万
  • 财政年份:
    2019
  • 负责人:
    Jacob M. Hooker
  • 依托单位:
国内基金
海外基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
  • 批准号:
    81801389
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    田茗源
  • 依托单位:
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
  • 批准号:
    81101046
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2011
  • 负责人:
    黄静
  • 依托单位: